Tag: Todos

Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL protease related IPDr. Dorit Arad, ...

 Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL protease related IP Dr. Dorit Arad, ...

§  Interim Clinical Trial Data from Phase 2 expected in Q4/21 §  Nature Neuroscience and Cell Reports publications highlight 3CLpro (Mpro)’s complementary mechanisms of virus replication and immune suppression New York, NY, ...